BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6420306)

  • 1. Complement components and activation in primary biliary cirrhosis.
    Lindgren S; Laurell AB; Eriksson S
    Hepatology; 1984; 4(1):9-14. PubMed ID: 6420306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G; Sjöholm AG; Svensson B
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
    Sturfelt G; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that C1s participates in the alternative complement pathway.
    Volanakis JE; Schultz DR; Stroud RM
    Int Arch Allergy Appl Immunol; 1976; 50(1):68-80. PubMed ID: 1244208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of C1 subcomponents in chronic urticaria and angioedema.
    Laurell AB; Mårtensson U; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1977; 54(5):434-42. PubMed ID: 885628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
    Waldo FB; West CD
    Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
    Roncato M; Vial MC; Maillet F; Peltier A
    Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes and complement activation in primary biliary cirrhosis.
    Wands JR; Dienstag JL; Bhan AK; Feller ER; Isselbacher KJ
    N Engl J Med; 1978 Feb; 298(5):233-7. PubMed ID: 619265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in Indian childhood cirrhosis.
    Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
    Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
    Lockshin MD; Qamar T; Redecha P; Harpel PC
    Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of organic solvents on immunity indicators in serum.
    Stefanovic J; Starsia Z; Murgasová I; Absolonová O
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):1-7. PubMed ID: 3571967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
    Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Titers of nine complement components, conglutinin and C3b-inactivator in adult and fetal bovine sera.
    Triglia RP; Linscott WD
    Mol Immunol; 1980 Jun; 17(6):741-8. PubMed ID: 7432351
    [No Abstract]   [Full Text] [Related]  

  • 17. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune system in inflammatory bowel disease: I. Complement levels.
    Hodgson HJ; Potter BJ; Jewell DP
    Gut; 1977 Sep; 18(9):749-53. PubMed ID: 604196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for assaying nine bovine complement components and C3b-inactivator.
    Linscott WD; Triglia RP
    Mol Immunol; 1980 Jun; 17(6):729-40. PubMed ID: 7432350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.